Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,417Revenue $M20.9Net Margin (%)-200.3Z-Score24.8
Enterprise Value $M1,240EPS $-0.3Operating Margin %-202.8F-Score4
P/E(ttm))0Cash Flow Per Share $-0.2Pre-tax Margin (%)-200.3Higher ROA y-yY
Price/Book5.410-y EBITDA Growth Rate %-2.0Quick Ratio10.3Cash flow > EarningsY
Price/Sales39.65-y EBITDA Growth Rate %-12.9Current Ratio10.3Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-25.1Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)6ROE % (ttm)-28.4Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M238ROI % (ttm)-57.0Gross Margin Increase y-yY

Gurus Latest Trades with NVAX

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
NVAXJean-Marie Eveillard 2014-06-30 Add$3.69 - $5.13
($4.39)
$ 5.8132%Add 150%500,000
NVAXDavid Swensen 2014-03-31 Sold Out -0.23%$4.13 - $6.65
($5.59)
$ 5.814%Sold Out0
NVAXJean-Marie Eveillard 2014-03-31 Reduce-0.01%$4.13 - $6.65
($5.59)
$ 5.814%Reduce -75%200,000
NVAXDavid Swensen 2013-12-31 Buy 0.23%$2.76 - $5.16
($3.51)
$ 5.8166%New holding, 25398 sh.25,398
NVAXGeorge Soros 2013-12-31 Sold Out -0.02%$2.76 - $5.16
($3.51)
$ 5.8166%Sold Out0
NVAXGeorge Soros 2013-09-30 Buy 0.02%$2.25 - $3.39
($2.82)
$ 5.81106%New holding, 573000 sh.573,000
NVAXJean-Marie Eveillard 2013-09-30 Buy 0.01%$2.25 - $3.39
($2.82)
$ 5.81106%New holding, 800000 sh.800,000
NVAXJean-Marie Eveillard 2011-03-31 Sold Out $2.15 - $2.96
($2.44)
$ 5.81138%Sold Out0
NVAXJean-Marie Eveillard 2010-09-30 Add$2.01 - $2.34
($2.2)
$ 5.81164%Add 25%125,000
NVAXJean-Marie Eveillard 2010-06-30 Reduce$2.18 - $2.97
($2.46)
$ 5.81136%Reduce -52.65%100,000
NVAXJean-Marie Eveillard 2009-12-31 Buy 0.01%$2.53 - $4.41
($3.46)
$ 5.8168%New holding, 250000 sh.250,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

NVAX is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
NVAX Jean-Marie Eveillard 2014-09-30500,0000.210.01
Premium Most recent portfolio changes are included for Premium Members only!


NVAX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
EVANS GARY CDirector 2014-12-16Sell46,701$5.721.57view
EVANS GARY CDirector 2014-12-12Sell30,000$5.770.69view
Modi Rajiv I.Director 2014-11-20Sell518,889$5.0215.74view
Modi Rajiv I.Director 2014-11-18Sell1,481,111$516.2view
Hahn Timothy JonSVP, Manufacturing 2014-10-03Buy2,500$4.0543.46view
PHILLIPS BARCLAY ASVP, CFO 2014-10-03Buy5,000$4.1141.36view
Glenn Gregory MSVP, Research and Development 2014-09-26Sell16,809$4.1639.66view
Hahn Timothy JonSVP, Manufacturing 2014-09-25Buy9,000$4.1739.33view
Wilson Russell PSVP, Business Development 2014-07-31Buy4,989$2.28154.82view
Herrmann John A IIISVP, General Counsel 2014-07-31Buy8,950$2.28154.82view

Press Releases about NVAX :

    Quarterly/Annual Reports about NVAX:

    News about NVAX:

    Articles On GuruFocus.com
    comment on NVAX Mar 16 2013 
    comment on NVAX Mar 16 2013 
    Novavax Inc. Reports Operating Results (10-Q) Nov 08 2010 
    Novavax Inc. Reports Operating Results (10-Q) Aug 06 2010 
    Novavax Inc. Reports Operating Results (10-Q) May 10 2010 
    creiter note on NVAX Jan 03 2010 
    Novavax Inc. Reports Operating Results (10-Q) Nov 09 2009 
    Novavax Inc. Reports Operating Results (10-Q) Aug 10 2009 
    Novavax Reports Second Quarter 2009 Financial Results Aug 07 2009 
    Novavax Inc. Reports Operating Results (10-Q) May 11 2009 

    More From Other Websites
    Stock Market Video Analysis for Week Ending 12/12/14 Dec 12 2014
    Stock Market Video Analysis for Week Ending 12/5/14 Dec 05 2014
    Novavax to Present at the 26th Annual Piper Jaffray Healthcare Conference Nov 26 2014
    Novavax Gains on Fast Track Designation for RSV F Vaccine Nov 21 2014
    U.S. FDA Grants Fast Track Designation to Novavax’ RSV F-Protein Nanoparticle Vaccine for... Nov 20 2014
    U.S. FDA Grants Fast Track Designation to Novavax' RSV F-Protein Nanoparticle Vaccine for Protection... Nov 20 2014
    Today's Dead Cat Bounce Stock: Novavax (NVAX) Nov 18 2014
    Novavax Initiates Phase 2 Clinical Trial of Quadrivalent Seasonal Influenza VLP Nov 17 2014
    Novavax Initiates Phase 2 Clinical Trial of Quadrivalent Seasonal Influenza VLP Nov 17 2014
    NOVAVAX INC Financials Nov 14 2014
    Novavax to Present at the Jefferies Global Healthcare Conference Nov 13 2014
    Novavax Initiates Phase 1 Clinical Trial of RSV F Vaccine in Pediatric Subjects Nov 10 2014
    10-Q for Novavax, Inc. Nov 08 2014
    NOVAVAX INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Nov 06 2014
    NOVAVAX INC Files SEC form 10-Q, Quarterly Report Nov 06 2014
    Novavax meets 3Q profit forecasts Nov 06 2014
    Novavax meets 3Q profit forecasts Nov 06 2014
    Novavax Reports Third Quarter 2014 Financial Results Nov 05 2014
    Novavax Reports Third Quarter 2014 Financial Results Nov 05 2014
    Q3 2014 Novavax Inc Earnings Release - After Market Close Nov 05 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK